A Phase 2 proof-of-concept efficacy study for the treatment of Acute Exacerbations in Chronic Obstructive Pulmonary Disease (AECOPD)

Status: Planning

Phase of Trial: Phase II

Latest Information Update: 20 May 2023

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

12 May 2023 According to a Pulmatrix media release, the completed data analysis is expected to inform the study design of this study. company plans to pursue partnership opportunities to advance PUR1800 into a potential this Phase 2 clinical trial.
12 Apr 2021 According to a Pulmatrix media release, this study is not expected to commence until 2022.
19 Feb 2019 According to a Pulmatrix media release, the company expects to initiate CMC development work preparation for this study in 2019.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com